{"count": 17, "results": [{"_id": "35693440", "pmid": 35693440, "pmcid": "PMC9177453", "title": "The role of sodium lauryl sulfate on formulation of directly compressed tablets containing simvastatin and aspirin: Effect on drugs dissolution and gastric mucosa", "journal": "Saudi Pharm J", "authors": ["Alshora DH", "Ibrahim MA", "Zayed G", "Al Rwashed MA", "Abou-Taleb HA", "Ali MF"], "date": "2022-05-01T00:00:00Z", "doi": "10.1016/j.jsps.2022.02.006", "meta_date_publication": "2022 May", "meta_volume": "30", "meta_issue": "5", "meta_pages": "635-645", "score": 50264.363, "text_hl": "The results showed that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@ alone exhibited a gastroprotective effect on the induced @<m>DISEASE_Mental_Disorders</m> @DISEASE_MESH:D001523 @@@irritation@@@. ", "citations": {"NLM": "Alshora DH, Ibrahim MA, Zayed G, Al Rwashed MA, Abou-Taleb HA, Ali MF. The role of sodium lauryl sulfate on formulation of directly compressed tablets containing simvastatin and aspirin: Effect on drugs dissolution and gastric mucosa Saudi Pharm J. 2022 May;30(5):635-645. PMID: 35693440", "BibTeX": "@article{35693440, title={The role of sodium lauryl sulfate on formulation of directly compressed tablets containing simvastatin and aspirin: Effect on drugs dissolution and gastric mucosa}, author={Alshora DH and Ibrahim MA and Zayed G and Al Rwashed MA and Abou-Taleb HA and Ali MF}, journal={Saudi Pharm J}, volume={30}, number={5}, pages={635-645}}"}}, {"_id": "32387414", "pmid": 32387414, "title": "Simvastatin attenuated sickness behavior and fever in a murine model of endotoxemia.", "journal": "Life Sci", "authors": ["Oliveira MK", "Dos Santos RS", "Cabral LDM", "Vilela FC", "Giusti-Paiva A"], "date": "2020-08-01T00:00:00Z", "doi": "10.1016/j.lfs.2020.117701", "meta_date_publication": "2020 Aug 1", "meta_volume": "254", "meta_issue": "", "meta_pages": "117701", "score": 50258.473, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ attenuated @<m>DISEASE_Mental_Disorders</m> @DISEASE_MESH:D001523 @@@sickness behavior@@@ and @DISEASE_Fever @DISEASE_MESH:D005334 @@@fever@@@ in a @SPECIES_10090 @@@murine@@@ model of @DISEASE_Endotoxemia @DISEASE_MESH:D019446 @@@endotoxemia@@@.", "citations": {"NLM": "Oliveira MK, Dos Santos RS, Cabral LDM, Vilela FC, Giusti-Paiva A. Simvastatin attenuated sickness behavior and fever in a murine model of endotoxemia. Life Sci. 2020 Aug 1;254():117701. PMID: 32387414", "BibTeX": "@article{32387414, title={Simvastatin attenuated sickness behavior and fever in a murine model of endotoxemia.}, author={Oliveira MK and Dos Santos RS and Cabral LDM and Vilela FC and Giusti-Paiva A}, journal={Life Sci}, volume={254}, pages={117701}}"}}, {"_id": "36558987", "pmid": 36558987, "pmcid": "PMC9787673", "title": "Post-Marketing Surveillance of Statins:A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance", "journal": "Pharmaceuticals (Basel)", "authors": ["Pop G", "Farcaș A", "Butucă A", "Morgovan C", "Arseniu AM", "Pumnea M", "Teodoru M", "Gligor FG"], "date": "2022-12-10T00:00:00Z", "doi": "10.3390/ph15121536", "meta_date_publication": "2022 Dec 10", "meta_volume": "15", "meta_issue": "12", "meta_pages": "", "score": 50252.105, "text_hl": "From January 2004 to July 2021, a total of 8965 ADRs were reported for the Systems Organ Class (SOC) \"@<m>DISEASE_Mental_Disorders</m> @DISEASE_MESH:D001523 @@@psychiatric disorders@@@\", of which 88.64% were registered for @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ (3659), @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (2326) and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ (1962). ", "citations": {"NLM": "Pop G, Farcaș A, Butucă A, Morgovan C, Arseniu AM, Pumnea M, Teodoru M, Gligor FG. Post-Marketing Surveillance of Statins:A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance Pharmaceuticals (Basel). 2022 Dec 10;15(12):. PMID: 36558987", "BibTeX": "@article{36558987, title={Post-Marketing Surveillance of Statins:A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance}, author={Pop G and Farcaș A and Butucă A and Morgovan C and Arseniu AM and Pumnea M and Teodoru M and Gligor FG}, journal={Pharmaceuticals (Basel)}, volume={15}, number={12}}"}}, {"_id": "39575090", "pmid": 39575090, "title": "First documented case of Smith-Lemli-Opitz syndrome in Syria: clinical presentation, diagnosis, and experimental management with simvastatin.", "journal": "Oxf Med Case Reports", "authors": ["Aladia AH", "Hamdan S", "Alkheder A"], "date": "2024-11-20T00:00:00Z", "doi": "10.1093/omcr/omae129", "meta_date_publication": "2024 Nov", "meta_volume": "2024", "meta_issue": "11", "meta_pages": "omae129", "score": 50249.48, "text_hl": "The infant was treated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, which improved his @<m>DISEASE_Mental_Disorders</m> @DISEASE_MESH:D001523 @@@irritability@@@ and was well tolerated. ", "citations": {"NLM": "Aladia AH, Hamdan S, Alkheder A. First documented case of Smith-Lemli-Opitz syndrome in Syria: clinical presentation, diagnosis, and experimental management with simvastatin. Oxf Med Case Reports. 2024 Nov;2024(11):omae129. PMID: 39575090", "BibTeX": "@article{39575090, title={First documented case of Smith-Lemli-Opitz syndrome in Syria: clinical presentation, diagnosis, and experimental management with simvastatin.}, author={Aladia AH and Hamdan S and Alkheder A}, journal={Oxf Med Case Reports}, volume={2024}, number={11}, pages={omae129}}"}}, {"_id": "32016638", "pmid": 32016638, "title": "Simvastatin Improves Behavioral Disorders and Hippocampal Inflammatory Reaction by NMDA-Mediated Anti-inflammatory Function in MPTP-Treated Mice.", "journal": "Cell Mol Neurobiol", "authors": ["Yan J", "Liu A", "Fan H", "Qiao L", "Wu J", "Shen M", "Lai X", "Huang J"], "date": "2020-10-01T00:00:00Z", "doi": "10.1007/s10571-020-00804-7", "meta_date_publication": "2020 Oct", "meta_volume": "40", "meta_issue": "7", "meta_pages": "1155-1164", "score": 50249.363, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Improves @<m>DISEASE_Mental_Disorders</m> @DISEASE_MESH:D001523 @@@Behavioral Disorders@@@ and Hippocampal @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@Inflammatory@@@ Reaction by @CHEMICAL_N_Methylaspartate @CHEMICAL_MESH:D016202 @@@NMDA@@@-Mediated Anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ Function in @CHEMICAL_1_Methyl_4_phenyl_1_2_3_6_tetrahydropyridine @CHEMICAL_MESH:D015632 @@@MPTP@@@-Treated @SPECIES_10090 @@@Mice@@@.", "citations": {"NLM": "Yan J, Liu A, Fan H, Qiao L, Wu J, Shen M, Lai X, Huang J. Simvastatin Improves Behavioral Disorders and Hippocampal Inflammatory Reaction by NMDA-Mediated Anti-inflammatory Function in MPTP-Treated Mice. Cell Mol Neurobiol. 2020 Oct;40(7):1155-1164. PMID: 32016638", "BibTeX": "@article{32016638, title={Simvastatin Improves Behavioral Disorders and Hippocampal Inflammatory Reaction by NMDA-Mediated Anti-inflammatory Function in MPTP-Treated Mice.}, author={Yan J and Liu A and Fan H and Qiao L and Wu J and Shen M and Lai X and Huang J}, journal={Cell Mol Neurobiol}, volume={40}, number={7}, pages={1155-1164}}"}}, {"_id": "39244853", "pmid": 39244853, "title": "Elevated cerebrospinal fluid glial fibrillary acidic protein levels in Smith-Lemli-Opitz syndrome.", "journal": "Mol Genet Metab", "authors": ["Luke RA", "Cawley NX", "Rahhal S", "Selvaraman A", "Thurm A", "Wassif CA", "Porter FD"], "date": "2024-08-30T00:00:00Z", "doi": "10.1016/j.ymgme.2024.108570", "meta_date_publication": "2024 Aug 30", "meta_volume": "143", "meta_issue": "1-2", "meta_pages": "108570", "score": 50232.55, "text_hl": "Relative to an age-appropriate comparison group, we found that CSF @GENE_GFAP @GENE_2670 @@@GFAP@@@ levels were elevated 3.9-fold in @DISEASE_Smith_Lemli_Opitz_Syndrome @DISEASE_MESH:D019082 @@@SLOS@@@ (3980 +- 3732 versus 1010 +- 577 pg/ml, p = 0.0184). @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@, a @GENE_HMGCR @GENE_3156 @@@3-hydroxy-3-methylglutaryl-coenzyme A reductase@@@ inhibitor, has previously been shown to increase expression of hypomorphic @GENE_DHCR7 @GENE_1717 @@@DHCR7@@@ alleles and in a placebo-controlled trial improved serum @CHEMICAL_Sterols @CHEMICAL_MESH:D013261 @@@sterol@@@ levels and decreased @<m>DISEASE_Mental_Disorders</m> @DISEASE_MESH:D001523 @@@irritability@@@. ", "citations": {"NLM": "Luke RA, Cawley NX, Rahhal S, Selvaraman A, Thurm A, Wassif CA, Porter FD. Elevated cerebrospinal fluid glial fibrillary acidic protein levels in Smith-Lemli-Opitz syndrome. Mol Genet Metab. 2024 Aug 30;143(1-2):108570. PMID: 39244853", "BibTeX": "@article{39244853, title={Elevated cerebrospinal fluid glial fibrillary acidic protein levels in Smith-Lemli-Opitz syndrome.}, author={Luke RA and Cawley NX and Rahhal S and Selvaraman A and Thurm A and Wassif CA and Porter FD}, journal={Mol Genet Metab}, volume={143}, number={1-2}, pages={108570}}"}}, {"_id": "8345888", "pmid": 8345888, "title": "[Psychiatric disorders with use of simvastatin].", "journal": "Ned Tijdschr Geneeskd", "authors": ["Duits N", "Bos FM"], "date": "1993-06-26T00:00:00Z", "meta_date_publication": "1993 Jun 26", "meta_volume": "137", "meta_issue": "26", "meta_pages": "1312-5", "score": 50078.3, "text_hl": "[@<m>DISEASE_Mental_Disorders</m> @DISEASE_MESH:D001523 @@@Psychiatric disorders@@@ with use of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@].", "citations": {"NLM": "Duits N, Bos FM. [Psychiatric disorders with use of simvastatin]. Ned Tijdschr Geneeskd. 1993 Jun 26;137(26):1312-5. PMID: 8345888", "BibTeX": "@article{8345888, title={[Psychiatric disorders with use of simvastatin].}, author={Duits N and Bos FM}, journal={Ned Tijdschr Geneeskd}, volume={137}, number={26}, pages={1312-5}}"}}, {"_id": "20691674", "pmid": 20691674, "title": "Simvastatin enhances immune responses to Abeta vaccination and attenuates vaccination-induced behavioral alterations.", "journal": "Brain Res", "authors": ["Kou J", "Kim HD", "Jin J", "Cao D", "Li L", "Lalonde R", "Fukuchi K"], "date": "2010-10-14T00:00:00Z", "doi": "10.1016/j.brainres.2010.07.102", "meta_date_publication": "2010 Oct 14", "meta_volume": "1356", "meta_issue": "", "meta_pages": "102-11", "score": 50058.098, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ enhances immune responses to @GENE_APP @GENE_11820 @@@Abeta@@@ vaccination and attenuates vaccination-induced @<m>DISEASE_Mental_Disorders</m> @DISEASE_MESH:D001523 @@@behavioral alterations@@@.", "citations": {"NLM": "Kou J, Kim HD, Jin J, Cao D, Li L, Lalonde R, Fukuchi K. Simvastatin enhances immune responses to Abeta vaccination and attenuates vaccination-induced behavioral alterations. Brain Res. 2010 Oct 14;1356():102-11. PMID: 20691674", "BibTeX": "@article{20691674, title={Simvastatin enhances immune responses to Abeta vaccination and attenuates vaccination-induced behavioral alterations.}, author={Kou J and Kim HD and Jin J and Cao D and Li L and Lalonde R and Fukuchi K}, journal={Brain Res}, volume={1356}, pages={102-11}}"}}, {"_id": "27747681", "pmid": 27747681, "pmcid": "PMC5005588", "title": "Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series", "journal": "Drug Saf Case Rep", "authors": ["Cham S", "Koslik HJ", "Golomb BA"], "date": "2016-12-01T00:00:00Z", "doi": "10.1007/s40800-015-0024-2", "meta_date_publication": "2016 Dec", "meta_volume": "3", "meta_issue": "1", "meta_pages": "1", "score": 50054.938, "text_hl": "Case\tCase history\t \t1\tCase 1, a professionala male in his 40s with a history of @DISEASE_Psoriasis @DISEASE_MESH:D011565 @@@psoriasis@@@ and two negative stress SPECT tests, with no personal or family history of @<m>DISEASE_Mental_Disorders</m> @DISEASE_MESH:D001523 @@@psychiatric illness@@@, was placed on @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 80 mg for @DISEASE_Hyperlipidemias @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ (@CHEMICAL_Technetium @CHEMICAL_MESH:D013667 @@@TC@@@ 262 mg/dL, TRG 123 mg/dL, HDL 35 mg/dL, and LDL 202 mg/dL). ", "citations": {"NLM": "Cham S, Koslik HJ, Golomb BA. Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series Drug Saf Case Rep. 2016 Dec;3(1):1. PMID: 27747681", "BibTeX": "@article{27747681, title={Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series}, author={Cham S and Koslik HJ and Golomb BA}, journal={Drug Saf Case Rep}, volume={3}, number={1}, pages={1}}"}}, {"_id": "16088363", "pmid": 16088363, "title": "Short-term reduction in bone markers with high-dose simvastatin.", "journal": "Osteoporos Int", "authors": ["Rosenson RS", "Tangney CC", "Langman CB", "Parker TS", "Levine DM", "Gordon BR"], "date": "2005-10-01T00:00:00Z", "doi": "10.1007/s00198-005-1897-1", "meta_date_publication": "2005 Oct", "meta_volume": "16", "meta_issue": "10", "meta_pages": "1272-6", "score": 50054.22, "text_hl": "Short-term use of high-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ lowers the level of the serum bone marker bone-specific alkaline phosphatase, which suggests the possibility of @<m>DISEASE_Mental_Disorders</m> @DISEASE_MESH:D001523 @@@reduced bone turnover@@@.", "citations": {"NLM": "Rosenson RS, Tangney CC, Langman CB, Parker TS, Levine DM, Gordon BR. Short-term reduction in bone markers with high-dose simvastatin. Osteoporos Int. 2005 Oct;16(10):1272-6. PMID: 16088363", "BibTeX": "@article{16088363, title={Short-term reduction in bone markers with high-dose simvastatin.}, author={Rosenson RS and Tangney CC and Langman CB and Parker TS and Levine DM and Gordon BR}, journal={Osteoporos Int}, volume={16}, number={10}, pages={1272-6}}"}}]}